NuVision – a Nottingham-based company with a product that speeds up healing of eye conditions – has raised a further £1.1m investment. The funding has
NuVision are recruiting to field-based clinical product specialists to join our team Why NuVision? NuVision Biotherapies (www.nu-vision.co.uk) is a UK-based company dedicated to providing tissue-based
NuVision has an exciting opportunity to join our team as a Manufacturing Technician Employer profile NuVision Biotherapies (www.nu-vision.co.uk) is a leading UK-based company committed to
Two consultant ophthalmic surgeons will lead the teaching day on the application of dried amniotic membrane in a range of ophthalmic presentations The session will
Webinar round-up: Five clinicians from four NHS centres present on their case report applications of amniotic membrane in different ophthalmic conditions in a webinar sponsored
Clinicians from four NHS centres are collaborating to present their use of Omnigen, amniotic membrane in the treatment of ocular conditions. On Tuesday 4th October 2022
The Queen Victoria Hospital NHS Trust and Maidstone and Tunbridge NHS Trust have completed the first NuVision Fellowship Programme auditing patients with corneal disease, who
NuVision Biotherapies, a tissue-based technology company delivering ophthalmic and wound care solutions in the primary care and surgical setting, join the conference to increase their
Andy Hill and Noel Waters join the expanding NuVision Team. Andy is appointed as Chief Executive Officer and Noel as Chief Operating Officer as the
Employer profile NuVision (www.nu-vision.co.uk) is a leading UK wound care company, committed to developing and commercialising innovative high quality human tissue products. Our launch focus
